Company Monitoring Page for Shire

latest headlines for company on cafepharma

Shire CEO: Hemophilia will remain a core business
BioPharma Dive
Mon, 12/11/17 - 09:49 am
Tags:
Shire, Pharma CEOs, hemophilia, Flemming Ornskov
The Only 3 Big Pharma Companies Growing Market Share
Motley Fool
Tue, 11/7/17 - 09:59 am
Tags:
Bristol-Myers Squibb, Opdivo, Shire, Celgene
Mydayis sales shine as Shire still looks to divest neuro
BioPharma Dive
Sat, 10/28/17 - 11:07 pm
Tags:
Shire, Mydayis, earnings
Under breakup pressure, Shire cheers grumpy investors with Q3 earnings beat
Fierce Pharma
Fri, 10/27/17 - 02:45 pm
Tags:
Shire, earnings
What's next for biopharma Q3 earnings
Biopharma Dive
Sat, 10/21/17 - 09:50 pm
Tags:
earnings, Amgen, Bristol-Myers Squibb, Celgene, GSK, Gilead Sciences, AbbVie, Merck, Shire
Activist hedge fund angles for Shire breakup to revive struggling shares
Fierce Pharma
Mon, 10/16/17 - 09:22 pm
Tags:
Shire
Shire says trial shows new HAE drug significantly reduces attacks
Reuters
Tue, 09/12/17 - 10:15 am
Tags:
Shire, HAE, clinical trials, hereditary angiodema, SHP616
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
NY Shock Exchange
Wed, 09/6/17 - 09:11 am
Tags:
Allergan, Restasis, patents, Mylan Labs, Pfizer, Teva Pharmaceutical, Shire
Shire defends record as UBS cuts price target on staff satisfaction reviews
Reuters
Wed, 08/30/17 - 11:43 pm
Tags:
Shire, employees, Baxalta
Shire announces availability of MYDAYIS(TM) for ADHD treatment in the U.S.
Seeking Alpha
Mon, 08/28/17 - 10:00 am
Tags:
Shire, Mydayis, ADHD
Under fire from Shire, Roche grabs the VIP lane for top drug prospect emicizumab
Endpoints
Thu, 08/24/17 - 09:53 am
Tags:
Shire, Roche, emicizumab, hemophilia A
Shire hints at ADHD spinoff, but could someone step in and buy the neuro franchise?
Fierce Pharma
Thu, 08/3/17 - 06:39 pm
Tags:
Shire, ADHD, spinoffs
Shire plots an ADHD public spinoff as CEO Ornskov completes a top-to-bottom overhaul
Endpoints
Thu, 08/3/17 - 11:01 am
Tags:
Shire, ADHD, Flemming Ornskov, spinoffs, Mydayis
Shire increasingly vulnerable to takeover attempts by big pharma companies
GoInPharma
Wed, 08/2/17 - 09:22 am
Tags:
Shire, M&A
5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings
Yahoo/Zacks.com
Thu, 07/13/17 - 09:49 am
Tags:
earnings, Merck, Eli Lilly, Celgene, Gilead Sciences, Shire
Shire blasts rival Roche for its “misleading” case for hemophilia trailblazer emicizumab
Motley Fool
Sun, 07/9/17 - 07:39 pm
Tags:
Shire, Roche, hemophilia, emicizumab
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
Bloomberg
Fri, 07/7/17 - 10:31 am
Tags:
rare disease, healthcare reform, Shire, Jazz Pharmaceuticals, Sanofi, Roche, Biogen, Alexion, Vertex Pharmaceuticals
Shire will cut U.S. locations and move HQ in consolidation push
Fierce Biotech
Wed, 07/5/17 - 11:23 am
Tags:
Shire, reorganization, consolidation, R&D
Shire’s Ornskov dictates another big revamp, with R&D/HQ moving into Cambridge
Endpoints
Sat, 07/1/17 - 09:25 am
Tags:
Shire, Flemming Ornskov, R&D, reorganization, Cambridge
Pfizer Fueling Growth Of Competitors' Pipelines
Forbes
Tue, 06/27/17 - 10:02 am
Tags:
Pfizer, R&D, Clovis Oncology, Puma Biotechnology, Bioventus, Shire, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.